Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancer
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
To explore how DOCK1 deficiency enhances the anti-tumor effects of metformin, we performed RNA-seq analysis in PLC cells expressing NTC or shDOCK1 in the presence or absence of metformin. RNA-seq analysis in PLC cells expressing NTC or shDOCK1 in the presence or absence of metformin.
创建时间：
2021-12-31
